Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in rats

This publication has 17 references indexed in Scilit:

• Relative mutagenicity and teratogenicity of cyclophosphamide and two of its structural analogs
  Biochemical Pharmacology, 1983
• Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2′-dithio-bis-ethane sulfonate (dimesna)
  Cancer, 1983
• Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)
  European Journal of Cancer and Clinical Oncology, 1982
• Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1981
• Modification of the teratogenicity and mutagenicity of cyclophosphamide with thiol compounds
  Teratology, 1981
• Characteristics of the activation of cyclophosphamide to a mutagen by rat liver
  Biochemical Pharmacology, 1980
• The Development of Mesna for the Inhibition of Urotoxic Side Effects of Cyclophosphamide, Ifosfamide, and Other Oxazaphosphorine Cytostatics
  Published by Springer Nature ,1980
• Cyclophosphamide cystitis—Identification of acrolein as the causative agent
  Biochemical Pharmacology, 1979
• Teratogenic bioactivation of cyclophosphamide
  Life Sciences, 1979
• Effect of radioprotectors on damage induced by alkylating agents on tumoural and normal tissues
  European Journal of Cancer (1965), 1966